SEC Form 4 · accession 0001493152-26-036577
Lipocine Inc. · LPCN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Grissinger
Director
Period of report
Aug 3, 2026
Accepted (ET)
Aug 7, 2026 · 4:11 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001535955
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.11 | Aug 3, 2026 | A | 2,000 | A | Aug 3, 2027 | Aug 3, 2036 | Common Stock | 2,000 | 2,000 | D |
Explanation of responses
- F1Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of August 3, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years.